Video

Findings help investigators understand how FDA-approved AGN-19058 behaves

Author(s):

Kassi Filkins
Conferences|ASCRS

George Waring, MD, discusses the findings of a retrospective study on Allergan’s AGN-190584 for the treatment of presbyopia.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Tiimes) EyeCon 2025: Sruthi Arepalli, MD, spotlights a deep dive orbital tour of the eye
Related Content
Q&A: Timothy Lai on the SALWEEN trial
September 11th 2025

Q&A: Timothy Lai on the SALWEEN trial

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
September 11th 2025

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

(Image credit: AdobeStock/Harsha) Inside Northwestern University’s “Dinner with the Experts” educational series with Robert S. Feder, MD
September 11th 2025

Q&A: Inside Northwestern University’s “Dinner with the Experts” educational series with Robert S. Feder, MD

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
September 11th 2025

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

(Image credit: AdobeStock/racesy) Q&A: Inside the CCOI Myopia Workshop with Assoc Prof Daniel Ting
September 11th 2025

Q&A: Inside the CCOI Myopia Workshop with Assoc Prof Daniel Ting

Post-LASIK presbyopia: Meeting expectations with evolving technology
September 11th 2025

Post-LASIK presbyopia: Meeting expectations with evolving technology

© 2025 MJH Life Sciences

All rights reserved.